[HTML][HTML] Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders

FV Brozovich, CJ Nicholson, CV Degen, YZ Gao… - Pharmacological …, 2016 - Elsevier
The smooth muscle cell directly drives the contraction of the vascular wall and hence
regulates the size of the blood vessel lumen. We review here the current understanding of …

Sleep apnea and cardiovascular disease: An American heart association/American college of cardiology foundation scientific statement from the American heart …

VK Somers, DP White, R Amin, WT Abraham… - Journal of the American …, 2008 - jacc.org
Sleep-related breathing disorders are highly prevalent in patients with established
cardiovascular disease. Obstructive sleep apnea (OSA) affects an estimated 15 million adult …

Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report

JR Klinger, CG Elliott, DJ Levine, E Bossone, L Duvall… - Chest, 2019 - Elsevier
Background Pulmonary arterial hypertension (PAH) carries a poor prognosis if not promptly
diagnosed and appropriately treated. The development and approval of 14 medications over …

Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical …

P Monagle, AKC Chan, NA Goldenberg, RN Ichord… - Chest, 2012 - Elsevier
Background Neonates and children differ from adults in physiology, pharmacologic
responses to drugs, epidemiology, and long-term consequences of thrombosis. This …

Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era

M Humbert, O Sitbon, A Chaouat, M Bertocchi… - Circulation, 2010 - ahajournals.org
Background—Novel therapies have recently become available for pulmonary arterial
hypertension. We conducted a study to characterize mortality in a multicenter prospective …

Pulmonary arterial hypertension in France: results from a national registry

M Humbert, O Sitbon, A Chaouat… - American journal of …, 2006 - atsjournals.org
Rationale: Pulmonary arterial hypertension (PAH) is an orphan disease for which the trend
is for management in designated centers with multidisciplinary teams working in a shared …

Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry

DB Badesch, GE Raskob, CG Elliott, AM Krichman… - Chest, 2010 - Elsevier
Background The Registry to EValuate Early And Long-term pulmonary arterial hypertension
disease management (REVEAL Registry) was established to provide updated …

Diagnosis and assessment of pulmonary arterial hypertension

DB Badesch, HC Champion… - Journal of the American …, 2009 - jacc.org
The diagnosis and assessment of pulmonary arterial hypertension is a rapidly evolving area,
with changes occurring in the definition of the disease, screening and diagnostic techniques …

Interstitial lung disease guideline

AU Wells, N Hirani - Thorax, 2008 - thorax.bmj.com
1. INTRODUCTION 1.1 An overview of the ILD guideline Since the publication of the first
BTS guidelines for diffuse lung disease nearly 10years ago, 1 the specialty has seen …

Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure

NF Voelkel, RA Quaife, LA Leinwand, RJ Barst… - Circulation, 2006 - ahajournals.org
Knowledge about the role of the right ventricle in health and disease historically has lagged
behind that of the left ventricle. Less muscular, restricted in its role to pum** blood through …